Pravastatin-d3 (sodium salt)
Modify Date: 2024-01-12 17:44:16
Pravastatin-d3 (sodium salt) structure
|
Common Name | Pravastatin-d3 (sodium salt) | ||
|---|---|---|---|---|
| CAS Number | 1329836-90-9 | Molecular Weight | 449.528 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H32D3NaO7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Pravastatin-d3 (sodium salt)Pravastatin-d3 (CS-514-d3) sodium salt is the deuterium labeled Pravastatin sodium salt. Pravastatin (CS-514) sodium salt is a competitive HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM[1][2]. |
| Name | Pravastatin-d3 (sodium salt) |
|---|---|
| Synonym | More Synonyms |
| Description | Pravastatin-d3 (CS-514-d3) sodium salt is the deuterium labeled Pravastatin sodium salt. Pravastatin (CS-514) sodium salt is a competitive HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
| References |
| Molecular Formula | C23H32D3NaO7 |
|---|---|
| Molecular Weight | 449.528 |
| Exact Mass | 449.246887 |
| 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-β,δ,6-trihydroxy-2-methyl-8-[(2S)-2-(methyl-d3)-1-oxobutoxy]-, sodium salt, (βR,δR,1S,2S,6S,8S,8aR)- (1:1) |
| Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-(2H3)methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthalenyl]heptanoate |
| Pravastatin-d3 (sodium salt) |